Onconetix Conducts Exempt Equity Sales Under Regulation D

Onconetix (ONCO) has released an update to notify the public and investors about the unregistered sales of equity securities.

The Debenture issuance referenced in the Current Report on Form 8-K was conducted under an exemption from registration in compliance with Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Regulation D.

For further insights into ONCO stock, check out TipRanks’ Stock Analysis page.